These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 20671758)
21. Molecule of the Month. Denosumab. Drug News Perspect; 2009; 22(6):356. PubMed ID: 19771324 [No Abstract] [Full Text] [Related]
22. Emerging treatments for postmenopausal osteoporosis - focus on denosumab. Geusens P Clin Interv Aging; 2009; 4():241-50. PubMed ID: 19554095 [TBL] [Abstract][Full Text] [Related]
23. Denosumab, osteoporosis, and prevention of fractures. Kiechl S; Willeit J; Schett G N Engl J Med; 2009 Nov; 361(22):2188-9; author reply 2190-1. PubMed ID: 19940304 [No Abstract] [Full Text] [Related]
24. Denosumab: in cancer treatment-induced bone loss. Muir VJ; Scott LJ BioDrugs; 2010 Dec; 24(6):379-86. PubMed ID: 21043545 [TBL] [Abstract][Full Text] [Related]
25. Denosumab, osteoporosis, and prevention of fractures. Blackwood J N Engl J Med; 2009 Nov; 361(22):2189; author reply 2190-1. PubMed ID: 19950411 [No Abstract] [Full Text] [Related]
26. Osteoporosis treatment options expand. Mayo Clin Health Lett; 2010 Nov; 28(11):4. PubMed ID: 21158019 [No Abstract] [Full Text] [Related]
27. Denosumab, osteoporosis, and prevention of fractures. Blythe SL N Engl J Med; 2009 Nov; 361(22):2189-90; author reply 2190-1. PubMed ID: 19950410 [No Abstract] [Full Text] [Related]
28. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women. Bone HG; Bolognese MA; Yuen CK; Kendler DL; Wang H; Liu Y; San Martin J J Clin Endocrinol Metab; 2008 Jun; 93(6):2149-57. PubMed ID: 18381571 [TBL] [Abstract][Full Text] [Related]
29. [Innovations in the treatment of osteoporosis]. Tsourdi E; Hofbauer LC Dtsch Med Wochenschr; 2011 Dec; 136(48):2458-60. PubMed ID: 22109575 [No Abstract] [Full Text] [Related]
30. [Austrian guidance for the pharmacologic treatment of osteoporosis in postmenopausal women: Addendum 2010]. Dimai HP; Pietschmann P; Resch H; Preisinger E; Fahrleitner-Pammer A; Dobnig H; Klaushofer K; Wien Med Wochenschr; 2010 Dec; 160(21-22):586-9. PubMed ID: 21170699 [TBL] [Abstract][Full Text] [Related]
31. [The role of rank-ligand inhibition in the treatment of postmenopausal osteoporosis]. Varenna M; Gatti D Reumatismo; 2010; 62(3):163-71. PubMed ID: 21052563 [TBL] [Abstract][Full Text] [Related]
32. Injection of hope. Elliott M Nurs Stand; 2010 Nov 10-16; 25(10):23. PubMed ID: 21155482 [TBL] [Abstract][Full Text] [Related]
34. Osteoporosis drug licensed for women with high fracture risk. Traynor K Am J Health Syst Pharm; 2010 Jul; 67(13):1046. PubMed ID: 20554585 [No Abstract] [Full Text] [Related]
35. [Denosumab for treatment of postmenopausal osteoporosis]. Syversen U; Halse JI; Geisler J; Eriksen EF Tidsskr Nor Laegeforen; 2011 Oct; 131(19):1893-6. PubMed ID: 21984295 [TBL] [Abstract][Full Text] [Related]
36. [Denosumab efficient against osteoporosis. A biological drug gives new possibilities to treat a public disease]. Törring O Lakartidningen; 2010 Mar 3-9; 107(9):574-5. PubMed ID: 20387753 [No Abstract] [Full Text] [Related]
37. Denosumab for the treatment of osteoporosis. Iqbal J; Sun L; Zaidi M Curr Osteoporos Rep; 2010 Dec; 8(4):163-7. PubMed ID: 20857349 [TBL] [Abstract][Full Text] [Related]
38. Bone complications of androgen deprivation therapy: screening, prevention, and treatment. Lattouf JB; Saad F Curr Opin Urol; 2010 May; 20(3):247-52. PubMed ID: 20224416 [TBL] [Abstract][Full Text] [Related]
39. Osteoporosis in men: what has changed? Adler RA Curr Osteoporos Rep; 2011 Mar; 9(1):31-5. PubMed ID: 21113693 [TBL] [Abstract][Full Text] [Related]
40. Study shows that a new type of osteoporosis drug reduces fracture risk. Harv Womens Health Watch; 2009 Oct; 17(2):6-7. PubMed ID: 19998553 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]